Dalen Meeter - 15 Dec 2024 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Financial Officer
Signature
/s/ Dalen Meeter
Issuer symbol
N/A
Transactions as of
15 Dec 2024
Net transactions value
$0
Form type
4
Filing time
17 Dec 2024, 17:34:31 UTC
Previous filing
13 Nov 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +209 +2.4% 9,002 15 Dec 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -209 -10% 1,874 15 Dec 2024 Common Stock 209 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
F3 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4 The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.